2BB score and signals
Keros Therapeutics, Inc.’s current 2BB score is 51 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 53 | Moderate |
| Momentum | 49 | Stable |
| Financial strength | 36 | Weak |
| Quality | 80 | Very Strong |
| Risk | 43 | Moderate |
Company facts
| Headquarters | Lexington, Massachusetts, United States |
| Founded | 2015 |
| Employees | 92 |
| 52-week range | $9.69 – $22.55 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-03 | — | -0.9588 | — | $15.06M |
| 2026-08-12 | — | -1.3668 | — | $823,282.00 |
| 2026-05-14 | -1.21 | -1.0433 | $367,000.00 | $594,996.00 |
| 2026-03-04 | -0.86 | -0.6413 | $385,000.00 | $2.81M |
Related companies
2BBBullish & Bearish